Corticosteroid Management of Coronavirus 2019 (COVID-19) in Patients with Bilateral Adrenalectomy

Autor:	William K. Lim, Frederick Lim
Rok vydání:	2021
Předmět:	Pediatrics medicine.medical_specialty medicine.drug_class business.industry Case Report Infectious and parasitic diseases RC109-216 General Medicine medicine.disease_cause medicine.disease Mineralocorticoid Pandemic medicine Adrenal insufficiency Corticosteroid Medical history business hormones hormone substitutes and hormone antagonists Dexamethasone Glucocorticoid Coronavirus medicine.drug
Zdroj:	Case Reports in Infectious Diseases Case Reports in Infectious Diseases, Vol 2021 (2021)
ISSN:	2090-6633 2090-6625
Popis:	Since the World Health Organization (WHO) announced coronavirus 2019 (COVID-19) as a pandemic in March 2020, it has been wreaking havoc across countries, affecting people’s lives. Corticosteroids have proven to provide a mortality benefit in patients with COVID-19. Although dexamethasone is the most commonly used glucocorticoid and have shown to have mortality benefit in COVID-19 patients, it cannot be used in patients with adrenal insufficiency due to its lack of mineralocorticoid activity. Herein, we discuss a case of challenging corticosteroid management in a patient with COVID-19 complicated by her medical history of bilateral adrenalectomy.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a249043da6a1378554860632755c6245 https://doi.org/10.1155/2021/5856600 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.